Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,004 | -3,052 | -16,739 | -13,822 | -11,248 |
| Depreciation Amortization | 2 | 1 | 5,190 | 5,189 | 5,188 |
| Accounts payable and accrued liabilities | 172 | -134 | 152 | -40 | 10 |
| Other Working Capital | 465 | -356 | 625 | 510 | 782 |
| Other Operating Activity | 38 | 232 | 504 | 605 | 461 |
| Operating Cash Flow | $-6,327 | $-3,309 | $-10,268 | $-7,558 | $-4,808 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -12 | -12 | -8 |
| Net Acquisitions | N/A | N/A | -507 | -507 | -452 |
| Investing Cash Flow | $N/A | $N/A | $-519 | $-519 | $-460 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,152 | N/A | 10,112 | 10,115 | 10,196 |
| Financing Cash Flow | $5,152 | $N/A | $10,112 | $10,115 | $10,196 |
| Exchange Rate Effect | 0 | 8 | -79 | -60 | -41 |
| Beginning Cash Position | 6,806 | 6,806 | 7,560 | 7,560 | 7,560 |
| End Cash Position | 5,631 | 3,505 | 6,806 | 9,538 | 12,447 |
| Net Cash Flow | $-1,175 | $-3,301 | $-754 | $1,978 | $4,887 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,327 | -3,309 | -10,268 | -7,558 | -4,808 |
| Capital Expenditure | N/A | N/A | -12 | -12 | -8 |
| Free Cash Flow | -6,327 | -3,309 | -10,280 | -7,570 | -4,816 |